This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, K.
Right arrow Articles by Yokochi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, K.
Right arrow Articles by Yokochi, T.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother., Oct 1997, 2295-2296, Vol 41, No. 10
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Low-level release of Shiga-like toxin (verocytotoxin) and endotoxin from enterohemorrhagic Escherichia coli treated with imipenem

K Takahashi, K Narita, Y Kato, T Sugiyama, N Koide, T Yoshida and T Yokochi
Department of Microbiology and Immunology, Aichi Medical University, Nagakute, Japan.

Shiga-like toxin (SLT) and endotoxin may participate in the pathogenesis of enterohemorrhagic Escherichia coli (EHEC) infection. Levels of release of SLT and endotoxin from EHEC treated in vitro with antibiotics were estimated. There were differential levels of release of SLT and endotoxin from EHEC treated with different antibiotics. Treatment of EHEC strains, namely, E. coli O157, O111, and O26, with imipenem induced much lower levels of release of SLT and endotoxin than treatment with ceftazidime.


This article has been cited by other articles:

  • Ochoa, T. J., Chen, J., Walker, C. M., Gonzales, E., Cleary, T. G. (2007). Rifaximin Does Not Induce Toxin Production or Phage-Mediated Lysis of Shiga Toxin-Producing Escherichia coli. Antimicrob. Agents Chemother. 51: 2837-2841 [Abstract] [Full Text]  
  • O'Ryan, M., Prado, V., Aragon, T., Fernyak, S., Reiter, R., Wong, C. S., Watkins, S. L., Tarr, P. I. (2000). Risk of the Hemolytic-Uremic Syndrome after Antibiotic Treatment of Escherichia coli O157:H7 Infections. NEJM 343: 1271-1273 [Full Text]  
  • Yokochi, T., Narita, K., Morikawa, A., Takahashi, K., Kato, Y., Sugiyama, T., Koide, N., Kawai, M., Fukada, M., Yoshida, T. (2000). Morphological Change in Pseudomonas aeruginosa following Antibiotic Treatment of Experimental Infection in Mice and Its Relation to Susceptibility to Phagocytosis and to Release of Endotoxin. Antimicrob. Agents Chemother. 44: 205-206 [Abstract] [Full Text]  
  • Sar, B., Oishi, K., Wada, A., Hirayama, T., Matsushima, K., Nagatake, T. (1999). Nitrite Reductase from Pseudomonas aeruginosa Released by Antimicrobial Agents and Complement Induces Interleukin-8 Production in Bronchial Epithelial Cells. Antimicrob. Agents Chemother. 43: 794-801 [Abstract] [Full Text]